Sfoglia per Soggetto "Kidney Transplantation"
Items 1-9 di 9
-
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation: A Systematic Review and Meta-Analysis
(2016)Background: Concerns exist over the extrapolation of bioavailability studies of generic immunosuppressive drugs in healthy volunteers, regarding their efficacy and safety in kidney transplant recipients. We conducted a ... -
A comparative analysis between proteasome and immunoproteasome inhibition in cellular and humoral alloimmunity
(2017)Triggered by the successful administration of the proteasome inhibitor bortezomib in kidney transplant recipients with acute or chronic antibody-mediated rejection, we evaluated the effect of the proteasome inhibitor ... -
The effect of anti‑HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation
(2021)In antibody‑mediated rejection (ABMR), the graft endothelium is at the forefront of the kidney transplant against the assault from the recipient's humoral immune system, and is a target of the latter. The present study ... -
A kidney transplant recipient with a perforated cheek: Oral epstein-barr virus-positive mucocutaneous ulcer complicated with an opportunistic bacterial infection
(2021)A 69-year-old female living donor kidney transplant recipient presented with right facial painful edema. The patient’s body mass index was 14 (kilograms per meter squared), and her creatinine clearance was 15 mL/min. A ... -
Molecular Aspects of Renal Immunology: Current Status and Future Perspectives
(2022)[No abstract available] -
Patterns of 1,748 Unique Human Alloimmune Responses Seen by Simple Machine Learning Algorithms
(2020)Allele specific antibody response against the polymorphic system of HLA is the allogeneic response marker determining the immunological risk for graft acceptance before and after organ transplantation and therefore routinely ... -
Quiz: Nine Years of Persistent, Disabling Foot Pain in a Kidney Transplant Recipient
(2017)[No abstract available] -
Rituximab Administered for Recurrent Membranous Nephropathy in a Kidney Transplant Recipient Did Not Eliminate Donor-Specific Antibodies
(2022)Chronic active antibody-mediated rejection is the leading cause of kidney transplant failure. Although various immunosuppressive agents have been tested, rituximab included, presently there is no effective treatment. There ... -
A role for human renal tubular epithelial cells in direct allo-recognition by CD4+ T-cells and the effect of ischemia-reperfusion
(2021)Direct allorecognition is the earliest and most potent immune response against a kidney allograft. Currently, it is thought that passenger donor professional antigen-presenting cells (APCs) are responsible. Further, many ...